Estrategias quirúrgicas en tumores limítrofes de ovario

Taylor, 1929, Malignant and semi-malignant tumors of the ovary, Surg Gynecol Obstet, 48, 204 International Federation of Gynecology and Obstetrics, 1971, Classification and staging of malignant tumours in the female pelvis, Acta Obstet Gynecol Scand, 50, 1, 10.3109/00016347109157278 Trope, 1998, Management of borderline tumors of the ovary: state of the art, Semin Oncol, 25, 372 Morice, 2012, Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence, Lancet Oncol, 13, e103115, 10.1016/S1470-2045(11)70288-1 Duvillard, 1996, Tumeurs ovariennes à la limite de la malignité, Ann Pathol, 16, 396 Kurman, 2014 Prat, 2014, Staging classification for cancer of the ovary, Fallopian tube, and peritoneum, Int J Gynaecol Obstet, 124, 1, 10.1016/j.ijgo.2013.10.001 Hauptmann, 2017, Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria, Virchows Arch, 470, 125, 10.1007/s00428-016-2040-8 Longacre, 2005, Ovarian serous tumors of low malignant potential (borderline tumors). Outcome-based study of 276 patients with long-term (>5-year) follow-up, Am J Surg Pathol, 29, 707, 10.1097/01.pas.0000164030.82810.db Kane, 2009, Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants, Oncologist, 14, 591, 10.1634/theoncologist.2008-0263 Morice, 2003, Prognostic factors for patients with advanced stage serous borderline tumours of the ovary, Ann Oncol, 14, 592, 10.1093/annonc/mdg173 Burks, 1996, Micropapillary serous carcinoma of the ovary: a distinctive low-grade carcinoma related to serous borderline tumors, Am J Surg Pathol, 20, 1319, 10.1097/00000478-199611000-00003 Bjorge, 1997, Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993, Int J Cancer, 71, 780, 10.1002/(SICI)1097-0215(19970529)71:5<780::AID-IJC15>3.0.CO;2-C Koskas, 2011, Prognostic factors of a large retrospective series of mucinous borderline tumors of the ovary (excluding peritoneal pseudomyxoma), Ann Surg Oncol, 18, 40, 10.1245/s10434-010-1293-8 Uzan, 2012, Management and prognosis of endometrioid borderline tumors of the ovary, Surg Oncol, 21, 178, 10.1016/j.suronc.2012.02.002 Uzan, 2012, Management and prognosis of clear cell borderline ovarian tumor, Int J Gynecol Cancer, 22, 993, 10.1097/IGC.0b013e3182534acf Uzan, 2012, Management and prognosis of borderline ovarian Brenner tumors, Int J Gynecol Cancer, 22, 1332, 10.1097/IGC.0b013e318267db2f Hannibal, 2017, A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma, Gynecol Oncol, 144, 174, 10.1016/j.ygyno.2016.11.007 Trimble, 2002, Long-term survival and patterns of care in women with ovarian carcinoma: a population-based analysis, Gynecol Oncol, 86, 34, 10.1006/gyno.2002.6711 Du Bois, 2013, Borderline tumours of the ovary: a cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group, Eur J Cancer, 49, 1905, 10.1016/j.ejca.2013.01.035 Kaern, 1993, A retrospective study of 370 borderline tumors of the ovary treated at the Norwegia Radium Hospital from 1970 to 1982, Cancer, 71, 1810, 10.1002/1097-0142(19930301)71:5<1810::AID-CNCR2820710516>3.0.CO;2-V Tamakoshi, 1997, Clinical behaviour of borderline ovarian tumors: a study of 150 cases, J Surg Oncol, 64, 147, 10.1002/(SICI)1096-9098(199702)64:2<147::AID-JSO11>3.0.CO;2-3 Gershenson, 1998, Ovarian serous borderline tumors with invasive peritoneal implants, Cancer, 82, 1096, 10.1002/(SICI)1097-0142(19980315)82:6<1096::AID-CNCR13>3.0.CO;2-1 Gershenson, 1998, Serous borderline tumors of the ovary with non invasive peritoneal implants, Cancer, 83, 2157, 10.1002/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D Daraï, 2013, Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options, Hum Reprod Update, 19, 151, 10.1093/humupd/dms047 Uzan, 2014, Influence of histological subtypes on the risk of an invasive recurrence in a large series of stage I borderline ovarian tumor including 191 conservative treatments, Ann Oncol, 25, 1312, 10.1093/annonc/mdu139 Trope, 1993, Are borderline tumors of the ovary overtreated both surgically and systemically?. A review of four prospective randomized trials including 253 patients with borderline tumors, Gynecol Oncol, 51, 236, 10.1006/gyno.1993.1279 Leake, 1991, Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential, Gynecol Oncol, 42, 124, 10.1016/0090-8258(91)90331-X Lin, 1999, The current status of surgical staging of ovarian serous borderline tumors, Cancer, 85, 905, 10.1002/(SICI)1097-0142(19990215)85:4<905::AID-CNCR19>3.0.CO;2-8 Lesieur, 2011, Prognostic value of lymph node involvement in ovarian serous borderline tumors, Am J Obstet Gynecol, 204, 438, 10.1016/j.ajog.2010.12.055 Yazigi, 1988, Primary staging in ovarian tumors of low malignant potential, Gynecol Oncol, 31, 402, 10.1016/S0090-8258(88)80024-6 Tan, 1994, Ovarian serous borderline tumors with lymph node involvement: clinicopathologic and DNA content study of seven cases and review of the literature, Am J Surg Pathol, 18, 904, 10.1097/00000478-199409000-00005 Sugarbaker, 1998, Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis, Semin Surg Oncol, 14, 254, 10.1002/(SICI)1098-2388(199804/05)14:3<254::AID-SSU10>3.0.CO;2-U Houck, 2000, Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis, Obstet Gynecol, 95, 839 Rose, 1994, Accuracy of frozen-section (intraoperative consultation) diagnosis of ovarian tumors, Am J Obstet Gynecol, 171, 823, 10.1016/0002-9378(94)90105-8 Yeo, 1998, The accuracy of intraoperative frozen section in the diagnosis of ovarian tumors, J Obstret Gynecol Res, 24, 189, 10.1111/j.1447-0756.1998.tb00074.x Lim-Tan, 1988, Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases, Obstet Gynecol, 72, 775 Zanetta, 2001, Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study, J Clin Oncol, 19, 2656, 10.1200/JCO.2001.19.10.2658 Park, 2009, Surgical management of borderline ovarian tumors: the role of fertility-sparing surgery, Gynecol Oncol, 113, 7582, 10.1016/j.ygyno.2008.12.034 Uzan, 2013, Fertility sparing treatment of recurrent stage I serous borderline ovarian tumours, Hum Reprod, 28, 3222, 10.1093/humrep/det371 Palomba, 2007, Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study, Hum Reprod, 22, 578, 10.1093/humrep/del381 Palomba, 2010, Ultra-conservative fertility-sparing strategy for bilateral borderline ovarian tumours: an 11-year follow-up, Hum Reprod, 25, 1966, 10.1093/humrep/deq159 Uzan, 2010, Outcomes after conservative treatment of advanced-stage serous borderline tumors of the ovary, Ann Oncol, 21, 51, 10.1093/annonc/mdp267 Prat, 2002, Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion, Am J Surg Pathol, 26, 1111, 10.1097/00000478-200209000-00002 Robinson, 1992, Operative staging and conservative surgery in the management of low malignant potential ovarian tumors, Int J Gynecol Cancer, 2, 113, 10.1046/j.1525-1438.1992.02030113.x Camatte, 2004, Impact of surgical staging in patients with macroscopic “stage I” ovarian borderline tumours: analysis of a continuous series of 101 cases, Eur J Cancer, 40, 1842, 10.1016/j.ejca.2004.04.017 Ozcan, 2015, Should we remove the normal-looking appendix during operations for borderline mucinous ovarian neoplasms? A retrospective study of 129 cases, Int J Surg, 18, 99, 10.1016/j.ijsu.2015.04.043 Young, 1990, Adjuvant therapy in stage I and stage II epithelial ovarian cancer, results of two prospective randomized trials, N Engl J Med, 322, 1021, 10.1056/NEJM199004123221501 Kurman, 1993, The behavior of serous tumors of low malignant potential: are they ever malignant?, Int J Gynecol Pathol, 12, 120, 10.1097/00004347-199304000-00006 Leary, 2014, Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants, Gynecol Oncol, 132, 23, 10.1016/j.ygyno.2013.11.006 Harter, 2014, Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors), Int J Gynecol Cancer, 24, S5, 10.1097/IGC.0000000000000282 Basille, 2006, Impact of gonadotropins and steroid hormones on borderline ovarian cells, Hum Reprod, 21, 3241, 10.1093/humrep/del301 Fortin, 2007, Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study, Fertil Steril, 87, 591, 10.1016/j.fertnstert.2006.07.1503 Uzan, 2011, How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary, Ann Oncol, 22, 631, 10.1093/annonc/mdq414 Prat, 2014, The results of conservative (fertility-sparing) treatment in borderline ovarian tumors vary depending on age and histological type, Ann Oncol, 25, 1255, 10.1093/annonc/mdu160